IM83 CAR-T cell therapy

IM83 CAR-T · Beijing Immunochina Medical Science & Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IM83 CAR-T cell therapy, covering 2024-05-14 to 2024-05-14. Get the full timeline:

Most recent: Clinical Trial Update: IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma [Phase 1]